{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:05:29Z","timestamp":1769069129599,"version":"3.49.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81970723"],"award-info":[{"award-number":["81970723"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Medical People Project in Jiangsu Province","award":["ZDRCA2016019"],"award-info":[{"award-number":["ZDRCA2016019"]}]},{"name":"Clinical Medical Research Institute of the Ili Prefecture","award":["yl2020py02"],"award-info":[{"award-number":["yl2020py02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Idiopathic inflammatory myopathy (IIM) is increasingly recognized as a systemic disorder with frequent subclinical myocardial involvement. However, its coexistence with heart failure with preserved ejection fraction (HFpEF) remains poorly understood. This study aimed to comprehensively characterize the clinical, serological and radiological features of IIM patients with HFpEF and assess the prognostic utility of the HFA-PEFF score in this setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cohort study, 134 patients with IIM were stratified into low-, intermediate- and high-risk categories according to their HFA-PEFF score. Clinical characteristics and long-term outcomes were compared across groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 134 patients, 22 (16.4%) were classified as high risk (HFA-PEFF \u22655). This group was significantly older and exhibited lower free triiodothyronine levels, higher CRP and cardiac troponin T levels (all P\u2009&amp;lt;\u20090.05), and a greater prevalence of interstitial lung disease with advanced pulmonary fibrosis. Late gadolinium enhancement on cardiac MRI was observed in 78.5% of high-risk patients. The high-risk group also had significantly higher positivity rates for ANA, anti-SSA, anti-Jo-1, and anti-Ro52 antibodies (P\u2009&amp;lt;\u20090.05), implicating a possible link between autoimmunity and myocardial remodelling. Kaplan\u2013Meier analysis revealed a markedly reduced 5-year survival in the high-risk group (47.1%) compared with the low- and intermediate-risk groups (88.7% and 84.5%, respectively; P\u2009&amp;lt;\u20090.001). In multivariable Cox regression, an HFA-PEFF score \u22655 remained an independent predictor of all-cause mortality (HR 3.124, P\u2009&amp;lt;\u20090.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings underscore the prognostic relevance of specific autoantibodies and cardiac fibrosis in IIM. Incorporating HFA-PEFF\u2013based risk stratification into clinical practice may enable earlier interventions and personalized monitoring for high-risk patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf643","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:54:25Z","timestamp":1764680065000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical features and prognosis of idiopathic inflammatory myopathy complicated by heart failure with preserved ejection fraction"],"prefix":"10.1093","volume":"65","author":[{"given":"Qi","family":"Hu","sequence":"first","affiliation":[{"name":"The Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing, Jiangsu 210029, People\u2019s Republic of","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyu","family":"Li","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, The First Affiliated Hospital with Nanjing Medical University , Nanjing, Jiangsu 210029, People\u2019s Republic of","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghong","family":"Tang","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing, Jiangsu 210029, People\u2019s Republic of","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxuan","family":"Sun","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, The First Affiliated Hospital with Nanjing Medical University , Nanjing, Jiangsu 210029, People\u2019s Republic of","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangyan","family":"Liu","sequence":"additional","affiliation":[{"name":"The Department of Radiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing, Jiangsu 210029, People\u2019s Republic of","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5607-9713","authenticated-orcid":false,"given":"Jiayi","family":"Dai","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing, Jiangsu 210029, People\u2019s Republic of","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing, Jiangsu 210029, People\u2019s Republic of","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangdi","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, The First Affiliated Hospital with Nanjing Medical University , Nanjing, Jiangsu 210029, People\u2019s Republic of","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3079-6383","authenticated-orcid":false,"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, The First Affiliated Hospital with Nanjing Medical University , Nanjing, Jiangsu 210029, People\u2019s Republic of","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5985-3177","authenticated-orcid":false,"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University , Nanjing, Jiangsu 210029, People\u2019s Republic of","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"2026012111515509500_keaf643-B1","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/S2665-9913(23)00322-3","article-title":"Idiopathic inflammatory myopathies: current insights and future frontiers","volume":"6","author":"Connolly","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"2026012111515509500_keaf643-B2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026012111515509500_keaf643-B3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10741-019-09909-8","article-title":"Cardiovascular complications in patients with idiopathic inflammatory myopathies: does heart matter in idiopathic inflammatory myopathies?","volume":"26","author":"Opinc","year":"2021","journal-title":"Heart Fail Rev"},{"key":"2026012111515509500_keaf643-B4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","article-title":"Heart failure with preserved ejection fraction: everything the clinician needs to know","volume":"403","author":"Campbell","year":"2024","journal-title":"Lancet"},{"key":"2026012111515509500_keaf643-B5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012111515509500_keaf643-B6","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jama.2024.3669","article-title":"Interstitial lung disease: a review","volume":"331","author":"Maher","year":"2024","journal-title":"JAMA"},{"key":"2026012111515509500_keaf643-B7","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"2026012111515509500_keaf643-B8","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1002\/ehf2.14131","article-title":"Evaluation of the HFA-PEFF Score: results from the prospective DIAST-CHF cohort","volume":"9","author":"Hashemi","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012111515509500_keaf643-B9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jchf.2020.03.013","article-title":"Application of diagnostic algorithms for heart failure with preserved ejection fraction to the community","volume":"8","author":"Selvaraj","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2026012111515509500_keaf643-B10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13075-023-03131-6","article-title":"Value of the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the inflammatory myopathy population","volume":"25","author":"Shi","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"2026012111515509500_keaf643-B11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jare.2022.03.003","article-title":"iNOS contributes to heart failure with preserved ejection fraction through mitochondrial dysfunction and Akt S-nitrosylation","volume":"43","author":"Guo","year":"2023","journal-title":"J Adv Res"},{"key":"2026012111515509500_keaf643-B12","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026012111515509500_keaf643-B13","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012111515509500_keaf643-B14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1164\/ajrccm.159.1.9803066","article-title":"Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis","volume":"159","author":"Casarini","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012111515509500_keaf643-B15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/rheumatology\/keab271","article-title":"Myocardial involvement characteristics by cardiac MR imaging in patients with polymyositis and dermatomyositis","volume":"61","author":"Feng","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026012111515509500_keaf643-B16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","article-title":"Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study","volume":"77","author":"Dobloug","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026012111515509500_keaf643-B17","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/ehf2.15247","article-title":"H2FPEF and HFA-PEFF scores for heart failure risk stratification in hypertrophic cardiomyopathy patients","volume":"12","author":"Gao","year":"2025","journal-title":"ESC Heart Fail"},{"key":"2026012111515509500_keaf643-B18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12872-025-04691-y","article-title":"The prognostic value of HFA-PEFF score in connective tissue disease-associated PAH: evidence from a cohort study","volume":"25","author":"Dai","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012111515509500_keaf643-B19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"2026012111515509500_keaf643-B20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2213-8587(23)00227-9","article-title":"The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis","volume":"11","author":"Xu","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026012111515509500_keaf643-B21","doi-asserted-by":"crossref","first-page":"614030","DOI":"10.3389\/fcell.2020.614030","article-title":"Thyroid hormones interaction with immune response, inflammation and non-thyroidal illness syndrome","volume":"8","author":"De Luca","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026012111515509500_keaf643-B22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","article-title":"Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/Ro-positive mothers","volume":"76","author":"Izmirly","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026012111515509500_keaf643-B23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jaut.2015.09.003","article-title":"Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7\/8 ligation to forestall tissue injury in anti-Ro60 associated heart block","volume":"67","author":"Clancy","year":"2016","journal-title":"J Autoimmun"},{"key":"2026012111515509500_keaf643-B24","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3892\/etm.2015.2694","article-title":"Anti-mitochondrial M2 antibody-positive autoimmune hepatitis","volume":"10","author":"Tomizawa","year":"2015","journal-title":"Exp Ther Med"},{"key":"2026012111515509500_keaf643-B25","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/ehjci\/jeae178","article-title":"Diastolic dysfunction in hypertension: a comprehensive review of pathophysiology, diagnosis, and treatment","volume":"25","author":"Ottosen","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012111515509500_keaf643-B26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026012111515509500_keaf643-B27","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/jama.2023.8753","article-title":"CD19-targeting CAR T cells for myositis and interstitial lung disease associated with antisynthetase syndrome","volume":"329","author":"Pecher","year":"2023","journal-title":"JAMA"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf643\/65728460\/keaf643.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/1\/keaf643\/65728460\/keaf643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/1\/keaf643\/65728460\/keaf643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:52:05Z","timestamp":1769014325000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf643\/8363897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf643","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,3]]},"article-number":"keaf643"}}